a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions
Industry Biotechnology
A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To LCTX | 1D Price Change % | ||
---|---|---|---|---|
LCTX | 100% | -16.02% | ||
MDGL - LCTX | 43% Loosely correlated | +5.53% | ||
APTO - LCTX | 36% Loosely correlated | -22.13% | ||
GBIO - LCTX | 34% Loosely correlated | +3.79% | ||
AXON - LCTX | 33% Loosely correlated | +0.90% | ||
MGTX - LCTX | 32% Poorly correlated | +0.17% | ||
More |